News
Analysts expect Johnson & Johnson to report an earnings per share (EPS) of $2.67. Johnson & Johnson bulls will hope to hear ...
13h
Zacks Investment Research on MSNHow Will Pfizer's Oncology Drugs Perform in Q2 Earnings?Pfizer PFE is one of the biggest players in the oncology space — a position it strengthened with the 2023 acquisition of ...
Analysts are estimating that Progressive will report an earnings per share (EPS) of $4.29. Investors in Progressive are eagerly awaiting the company's announcement, hoping for news of surpassing ...
12h
Zacks Investment Research on MSNPepsiCo (PEP) Q2 Earnings Preview: What You Should Know Beyond the Headline EstimatesIn its upcoming report, PepsiCo (PEP) is predicted by Wall Street analysts to post quarterly earnings of $2.03 per share, reflecting a decline of 11% compared to the same period last year. Revenues ...
Pfizer has caught investors’ eyes recently, outperforming its peers slightly but facing modest growth prospects ahead.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results